PubMed:25731749 / 317-403
Annnotations
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | proteinmutation |
|---|---|---|---|---|---|
| 25731749_1 | 16-22 | ProteinMutation | denotes | G2019S | rs34637584 |
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T43 | 23-31 | SO:0000109 | denotes | mutation |
| T44 | 45-60 | GO:0016301 | denotes | kinase activity |
| T45 | 64-69 | PR:Q5S006 | denotes | LRRK2 |
| T46 | 64-69 | PR:000003033 | denotes | LRRK2 |
| T47 | 64-69 | PR:Q5S007 | denotes | LRRK2 |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 0-86 | DRI_Background | denotes | The most common G2019S mutation enhances the kinase activity of LRRK2 in vitro whereas |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 0-86 | DRI_Background | denotes | The most common G2019S mutation enhances the kinase activity of LRRK2 in vitro whereas |